Evidence map›Paper›PMID 40062542›Full record

ArticleAmerican journal of hematology2025

Real-World Outcomes of Relapsed/Refractory Core-Binding Factor Acute Myeloid Leukemia: A COMMAND Registry Study.

Alexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, Oluwatobi Odetola, Yasmin Abaza, Nhi Nai, Charles E Foucar, Rohan K Achar, Rory M Shallis, Danielle Bradshaw and 5 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alexandra E RojekSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0003-1615-1447
Benjamin J McCormickDivision of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida, USA.
Joanna CwykielDivision of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Oluwatobi OdetolaDivision of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Yasmin AbazaDivision of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-9156-7912
Nhi NaiDepartment of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.ORCID https://orcid.org/0000-0002-3034-0896
Charles E FoucarDivision of Hematology and Oncology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
Rohan K AcharSection of Hematology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Rory M ShallisSection of Hematology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Danielle BradshawGeorgia Cancer Center, Augusta University, Augusta, Georgia, USA.
Meaghan StandridgeDepartment of Internal Medicine, Augusta University, Medical College of Georgia, Augusta, Georgia, USA.
Vamsi KotaGeorgia Cancer Center, Augusta University, Augusta, Georgia, USA.ORCID https://orcid.org/0000-0002-5290-9289
Guru Subramanian Guru MurthyDivision of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Talha BadarDivision of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida, USA.ORCID https://orcid.org/0000-0003-1548-918X
Anand A PatelSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-0296-8686

Funding

BASIC RESEARCH TRAINING IN MEDICAL ONCOLOGYT32CA009566 · NCI · UNIVERSITY OF CHICAGO · PI OLUFUNMILAYO F. OLOPADE · 1987 to 2026
$10.5M
NCI NIH HHS T32 CA009566NIH/NCI T32 CA009566-33
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AMLAML‐molecular diagnosis and therapycore‐binding factorrelapsed/refractory

Identifiers

PMID40062542
PMCPMC12068978

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.